Table 2

Patient characteristics by prosthesis type

CharacteristicMechanical prosthesis, (n=2239)Tissue prosthesis, (n=3231)p Value
Perioperative mortality, n (%) yes82 (4)188 (6)<0.001
Mean age (SD)58.5 (11.6)74.1 (7.5)<0.001
Male gender, n (%)1567 (70)1836 (57)<0.001
Concomitant CABG, n (%)445 (20)1195 (38)<0.001
Greater than first operation, n (%)49 (2)22 (1)<0.001
NYHA, n (%) asymptomatic77 (9)30 (2)<0.001
 n (%) I132 (15)130 (10)
 n (%) II297 (35)434 (33)
 n (%) III287 (34)612 (46)
 n (%) IV61 (7)116 (9)
LV function, n (%) normal (>50%)1261 (60)1899 (61)0.64
 n (%) moderate impairment (30–50%)655 (31)917 (30)
 n (%) severe impairment (<30%)184 (9)283 (9)
Diabetes, n (%) no2002 (92)2855 (89)<0.001
 n (%) IDDM60 (3)81 (3)
 n (%) Non-IDDM120 (5)275 (9)
AF/flutter, n (%) yes277 (16)712 (24)<0.001
Mean creatinine (SD) (mmol/l)110 (71)111 (49)0.51
Mean creatinine clearance (SD) (ml/min)78.1 (55.9)55.2 (29.2)<0.001
Mean EuroSCORE (SD)4.9 (2.9)7.2 (2.7)<0.001
Mean Parsonnet Score (SD)12.1 (7.3)20.7 (8.9)<0.001
  • AF, atrial fibrillation; CABG, coronary artery bypass grafting; IDDM, insulin-dependent diabetes mellitus; LV, left ventricular; NYHA, New York Heart Association. The percentages in this table are not based on the total number in each group.